Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report

Anaplastic large cell lymphoma (ALCL) with ALK-translocation constitutes an aggressive lymphoma with high sensitivity to anthracycline-based chemotherapy. Relapse, however, is observed in about one-third of patients. Salvage treatment incorporates high-dose chemotherapy followed by autologous or all...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dennis Christoph Harrer, Karin Menhart, Stephanie Mayer, Wolfgang Herr, Albrecht Reichle, Martin Vogelhuber
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020-10-01
Colecção:Frontiers in Oncology
Assuntos:
crizotinib
anaplastic large cell lymphoma
ALK
relapse
hematology
Acesso em linha:https://www.frontiersin.org/article/10.3389/fonc.2020.585830/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados